PME Full Year Results

Open PDF
Stock Pro Medicus Ltd (PME.ASX)
Release Time 14 Aug 2025, 9:22 a.m.
Price Sensitive Yes
 Pro Medicus Reports Record Full-Year Results
Key Points
  • Revenue up 31.9% to $213.0m
  • Underlying profit before tax up 40.2% to $163.3m
  • Net profit up 39.2% to $115.2m
  • Cash and other financial assets up 35.5% to $210.7m
  • Record year for new contract wins and renewals
Full Summary

Pro Medicus Limited, a leading healthcare informatics company, has announced its full-year results for the 12 months ending June 2025. The company reported a 31.9% increase in revenue from ordinary activities to $213.0 million, and a 40.2% rise in underlying profit before tax to $163.3 million. Net profit grew by 39.2% to $115.2 million. The company's cash and other financial assets at the end of June 2025 were $210.7 million, an increase of 35.5%. Pro Medicus remains debt-free. The company announced a fully-franked final dividend of 30 cents per share. Revenue increased across all key jurisdictions, with North America up 35.8%, Australia up 4.9%, and Germany up 8.6%. Pro Medicus secured $520 million in new contracts during the year, including major deals with Trinity Health, Duly Health and Care, University of Kentucky, Lurie Children's Hospital, BayCare, and Lucid Health. The company also announced $130 million in contract renewals, including with Mercy Health and a large Australian radiology network. In addition, Pro Medicus sold additional modules to existing clients NYU Langone and Duke Health. CEO Dr. Sam Hupert said the year represented a record for the company in terms of revenue, net profit, sales, and implementations, with the majority of the new contracts coming in the second half of the year and set to contribute to FY26 and beyond. The company also signed two new contracts post-June 30, including a $170 million 10-year deal with UCHealth and a $20 million 5-year renewal with Franciscan Missionaries of Our Lady Health System.

Guidance

Pro Medicus expects continued strong, profitable growth in FY26 and beyond, with the majority of the new contracts signed in FY25 set to contribute to future financial performance.

Outlook

The company's pipeline remains strong, with new opportunities spanning all key market segments including Academic Medical Centres, Integrated Delivery Networks (IDNs), and the private market. Pro Medicus continues to see cloud as a strategic advantage, as its competition has not been able to fully re-engineer their systems to take advantage of cloud technology.